287 related articles for article (PubMed ID: 16803862)
1. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
[TBL] [Abstract][Full Text] [Related]
2. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
3. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
O'Neill MJ; Murray TK; Whalley K; Ward MA; Hicks CA; Woodhouse S; Osborne DJ; Skolnick P
Eur J Pharmacol; 2004 Feb; 486(2):163-74. PubMed ID: 14975705
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor 5 modulates the nitric oxide-cGMP pathway in cerebellum in vivo through activation of AMPA receptors.
Boix J; Llansola M; Cabrera-Pastor A; Felipo V
Neurochem Int; 2011 Apr; 58(5):599-604. PubMed ID: 21300123
[TBL] [Abstract][Full Text] [Related]
6. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine-induced hippocampal CA1 neuron alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid (AMPA) receptor plasticity linked to severity of withdrawal anxiety: differential role of voltage-gated calcium channels and N-methyl-D-aspartic acid receptors.
Xiang K; Tietz EI
Behav Pharmacol; 2007 Sep; 18(5-6):447-60. PubMed ID: 17762513
[TBL] [Abstract][Full Text] [Related]
8. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.
Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G
Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096
[TBL] [Abstract][Full Text] [Related]
9. The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat.
Fowler JH; Whalley K; Murray T; O'neill MJ; McCulloch J
J Cereb Blood Flow Metab; 2004 Oct; 24(10):1098-109. PubMed ID: 15529010
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of chronic hyperammonemia on modulation of the glutamate-nitric oxide-cGMP pathway by metabotropic glutamate receptor 5 and low and high affinity AMPA receptors in cerebellum in vivo.
Cabrera-Pastor A; Llansola M; Reznikov V; Boix J; Felipo V
Neurochem Int; 2012 Jul; 61(1):63-71. PubMed ID: 22521775
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of neurite growth with AMPA receptor potentiation.
Voss OP; Milne S; Sharkey J; O'Neill MJ; McCulloch J
Neuropharmacology; 2007 Feb; 52(2):590-7. PubMed ID: 17101156
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
[TBL] [Abstract][Full Text] [Related]
13. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
14. Effects of AMPA and clomethiazole on spreading depression cycles in the rat neocortex in vivo.
Addae JI; Ali N; Stone TW
Eur J Pharmacol; 2011 Feb; 653(1-3):41-6. PubMed ID: 21147095
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cyclic GMP microdialysis study in rat cerebellum.
Fedele E; Raiteri M
Br J Pharmacol; 1996 Mar; 117(6):1133-8. PubMed ID: 8882607
[TBL] [Abstract][Full Text] [Related]
17. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn.
Haseneder R; Kratzer S; Kochs E; Mattusch C; Eder M; Rammes G
Anesthesiology; 2009 Dec; 111(6):1297-307. PubMed ID: 19934875
[TBL] [Abstract][Full Text] [Related]
18. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis.
Hermenegildo C; Monfort P; Felipo V
Hepatology; 2000 Mar; 31(3):709-15. PubMed ID: 10706562
[TBL] [Abstract][Full Text] [Related]
19. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
Partin KM; Mayer ML
Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
[TBL] [Abstract][Full Text] [Related]
20. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
Jayakar SS; Dikshit M
Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
